MedCost Clear Cost calculator

Drugs / Rinvoq

Rinvoq cost

upadacitinib · AbbVie. Every official price for Rinvoq, side by side, with who pays it.

Short answer

We found no list price published by AbbVie. Pharmacies paid an average of $229.37–$459.84 per tablet (NADAC, Oct 21, 2026). In 2024, Medicare Part D spent $1.4 billion on Rinvoq, an average of $7,147.55 per prescription fill before rebates (CMS). In Medicare Part D, the yearly out-of-pocket limit is $2,100 in 2026 and $2,400 in 2027.1523

Source: CMS, data.medicaid.gov (NADAC) and Medicare.gov · checked Nov 15, 2026

Rinvoq: the official numbers, by situation

PriceAmountWhose price, and who it applies toDate
List price Not published We found no list price published by AbbVie. —
Pharmacy cost (NADAC)
per tablet; a month depends on your dose
$229.37–$459.841 What pharmacies pay on average (CMS survey). Not a patient price. Oct 21, 2026

On Medicare drug coverage: 5,492 of 5,492 Part D plans list Rinvoq for 2027 (100%), and 98% of those require prior authorization, in CMS's formulary file published Oct 15, 2026.11 By year and tier

None of these is your price at the counter: that depends on how you pay. Details and sources for each number are further down.

FDA approval

Every official price

PriceAmountWhat it isDate
Maker's list price (WAC) Not published We found no current list price on AbbVie's own pages, so we do not show one. —
Pharmacy acquisition cost (NADAC)
Rinvoq ER 15 mg tablet
$229.501 Per tablet. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Rinvoq ER 30 mg tablet
$229.371 Per tablet. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Rinvoq ER 45 mg tablet
$459.841 Per tablet. The national average price pharmacies pay to buy it. Oct 21, 2026

These are prices the drug company, Medicare and pharmacies use. What you pay depends on your coverage; see below.

What Medicare spent on Rinvoq in 2024

CMS publishes what Part D spent on each drug each year. Its spending is the gross drug cost, which includes what Medicare, the plan and the patient paid,6 and it does not reflect manufacturers' rebates.7 CMS lists Rinvoq in 2 rows; together they come to $1.4 billion over 193,904 prescription fills, $7,147.55 per fill.

Medicare Part D, calendar year 2024 (CMS Medicare Part D Spending by Drug, checked Nov 15, 2026).

Product (as CMS lists it)Total spendingFillsPeoplePer fillPer person
Rinvoq $1.4 billion5 193,864 29,062 $7,146.568 $47,672.569
Rinvoq Lq $0.5 million5 40 15 $11,972.038 $31,925.429

These are totals and averages across everyone in Medicare who used the drug, not a price for one person. Averages per person depend on how long and how much each person used it.

Medicare Part D spending on Rinvoq, 2020–2024

CMS Medicare Part D Spending by Drug, "Rinvoq" (all makers), gross cost before rebates, checked Nov 15, 2026.

YearTotal spendingPrescription fillsPeoplePer fill
2020$191.3 million1235,2227,100$5,430.14
2021$411.5 million1270,36811,596$5,848.01
2022$622.1 million1299,52315,674$6,250.91
2023$976.3 million12142,48621,424$6,852.12
2024$1.4 billion12193,86429,062$7,146.56
Per fill = total spending ÷ fills (matches CMS's own average). Totals for everyone in Part D who used it, not a price for one person.

How many Medicare Part D plans list Rinvoq

Every Medicare drug plan in CMS's formulary file (standalone drug plans and Medicare Advantage plans with drug coverage). A plan counts when its drug list has at least one form or strength. Matched by RxNorm code and checked against the FDA NDC Directory. Plan counts, not people; to see your own plan's rules use Medicare Plan Finder.

Plan yearPlans that list itPrior auth.Step therapyQuantity limitLowest tier (plans)
2026 5,402 of 5,49610
98%
5,29705,271 tier 1: 156 · tier 2: 6 · tier 4: 46 · tier 5: 5,194
2027 5,492 of 5,49211
100%
5,39005,357 tier 1: 123 · tier 2: 1 · tier 4: 46 · tier 5: 5,322
2026: CMS file 2026_20260916.zip, published Sep 23, 2026 · 2027: CMS file 2027_20261008.zip, published Oct 15, 2026.

Being on a plan's list is not a price: what you pay depends on the tier and your plan. Each plan can divide its tiers in different ways. What prior authorization, step therapy and tiers mean.

With Medicare

With commercial insurance or no insurance

Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.

Official sources for this page (12)
  1. “Out-of-pocket limit Yearly $2,100 (in 2026).”
    Medicare.gov: Medicare costs · as of Oct 23, 2026
  2. “Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
  3. “NDA211675 ORIG-1 approved 20190816”
  4. “Rinvoq: Tot_Spndng_2024 1385459851.4, Tot_Clms_2024 193864, Tot_Benes_2024 29062; Rinvoq Lq: Tot_Spndng_2024 478881.33, Tot_Clms_2024 40, Tot_Benes_2024 15”
  5. “Drug spending metrics for Part D drugs are based on the gross drug cost, which represents total spending for the prescription claim, including Medicare, plan, and beneficiary payments.”
  6. “The Part D spending metrics do not reflect any manufacturers' rebates or other price concessions as CMS is prohibited from publicly disclosing such information.”
  7. “Part D drug spending divided by the number of prescription fills.”
  8. “Total Part D drug spending divided by the number of unique beneficiaries utilizing the drug during the benefit year.”
  9. “Rinvoq | Upadacitinib | Overall”

Did this page answer your question?